Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

29-Mar-17 - 27-Mar-18
Buy Ratio:44%

Up

# Net Buyers:114
# Net Sellers:147

Previous 52 Weeks

30-Mar-16 - 28-Mar-17
Buy Ratio:41%
# Net Buyers:133
# Net Sellers:194
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($7.60M)$1.84B  
Zoetis Inc.($598.49K)$792.01M  
China Biologic Products, Inc.($873.64K)$642.56M  
Catalent, Inc.($6.77M)$621.40M  
Bausch Health Companies Inc.($14.23M)$198.28M  
New Net Buyers
CompanyNet Buy AmountChange
Agios Pharmaceuticals Inc$70.74M$98.00M  
Acceleron Pharma Inc$21.12M$89.96M  
Akorn Inc$38.54M$52.65M  
Biogen Inc.$24.81M$44.31M  
Allergan Plc$16.58M$39.05M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.--($711.91M)  
Kite Pharma, Inc.($725.38M)($698.85M)  
Juno Therapeutics, Inc.($222.21M)($203.51M)  
Vertex Pharmaceuticals Inc / Ma($224.88M)($192.04M)  
Seattle Genetics Inc /wa($17.02M)($130.84M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($17.02M)($130.84M)  
Acadia Pharmaceuticals Inc($7.25M)($78.21M)  
Abbott Laboratories($38.83M)($64.06M)  
Calithera Biosciences, Inc.($9.12M)($15.68M)  
Recro Pharma, Inc.($7.83M)($10.68M)